About Me
Dr. Liu earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. His post-doctoral training was at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.
Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.
Language
Position
ASSISTANT PROFESSOR | Medicine, Infectious Diseases, ASSISTANT PROFESSOR | Medicine, Hospital Medicine, ASSISTANT PROFESSOR | MicrobiologyHospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
About Me
Dr. Liu earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. His post-doctoral training was at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.
Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.
Language
Position
ASSISTANT PROFESSOR | Medicine, Infectious Diseases, ASSISTANT PROFESSOR | Medicine, Hospital Medicine, ASSISTANT PROFESSOR | MicrobiologyHospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
About Me
Dr. Liu earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. His post-doctoral training was at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.
Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.
Language
Position
ASSISTANT PROFESSOR | Medicine, Infectious Diseases, ASSISTANT PROFESSOR | Medicine, Hospital Medicine, ASSISTANT PROFESSOR | MicrobiologyHospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
MD, UMDNJ Robert Wood Johnson Medical School
Residency, Internal Medicine
North Shore University Hospital
Fellowship, Infectious Diseases
The Mount Sinai Hospital
Certifications
Infectious Disease
American Board of Internal Medicine
Awards
2014
1st Place outstanding poster presentation
North Shore-LIJ Health System Annual Academic Competition – Educational outcomes research
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Liu during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors